Glioblastoma Treatment Drugs Market Trends and Dynamic Demand by 2032


 During the forecast period, the Glioblastoma Treatment Drugs Market is anticipated to grow at a CAGR of 5.7%. By 2022, the market is anticipated to be worth US$ 723.30 million, and by 2032, it is anticipated to be worth US$ 1,259.13 million.

Patients have started getting clinical trials with development agents. Biomarkers are more successful regarding personalized medicine. There is a likelihood of tumor getting located in spinal cord, which does represent close to 15% of all sorts of primary brain tumors. This actually drives the demand pertaining to glioblastoma treatment drugs.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/REP-GB-1248?utm_source=4018419&utm_medium=Sanket

Drugs that are involved in the treatment of glioblastoma are antineoplastic cytotoxic drugs. This is amongst the remarkable developments in the chemotherapy drugs for treating malignant tumors. Every passing year sees an influx of new drugs for overcoming blood-brain barrier. Manufacturers are on the toes. In other words, they are into extensive research regarding upgradation of drugs to treat glioblastoma.

Variation in treatment approach of patient to patient resulting in tumor heterogeneity is actually expected to account for rise in demand for ‘personalized treatment approach’ for managing glioblastoma multiforme. New treatments are on the way, and expected to increase the life-span of the patients contracting glioblastoma multiforme. Along these lines, the US FDA, in July 2020, did grant ‘fast track designation’ to DB102 (enzastaurin) from Denovo Biopharma to treat the patients who are diagnosed with this disease.

Radiation therapy holds more than 30% of the market share due to enhanced rates of survival. Using temozolomide with radiotherapy does increase the tumor’s sensitivity to radiation. So, it’s advisable to avoid it.

It also needs to be considered that glioblastoma is aa complex disease, which says that its treatment does involve numerous approaches combining several treatments. Not all the economies have a good understanding of the ailment. As such, they can’t boast of efficient treatment. This would, in turn, be highly dependent on the investment being put in. It’s actually to wait and watch the entire thing. Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Glioblastoma Treatment Drugs Market’.

Key Takeaways from Glioblastoma Treatment Drugs Market

  • North America holds more than 30% of the market share and the status quo is expected to remain the same even in the forecast period. This could be credited to the US alone being home to18K people diagnosed with glioblastoma.
  • Europe holds the second-largest market share. It, in fact, contributes for 27% of the revenue. As of now, 25K cases have been reported till date. The UK is leading from the front.
  • The Asia-Pacific is expected to witness the fastest growth in glioblastoma treatment drugs market with benevolence amongst the population.

Competitive Landscape

  • Merck company, in 2019, completed acquisition of Peloton Therapeutics (a bio-therapeutic clinical-stage organization) for helping in treatment of brain cancer. A small molecule has been strongly developed for treating hypoxia-inducible factor- 2α (HIF-2α).
  • Lineage Cell Therapeutics inked a licensing deal with Immunomic Therapeutics in April 2021 to create allogeneic VAC cancer immunotherapy platform (used for treating glioblastoma multiform). As per the deal, Lineage received US$ 2 Mn payment upfront, along with US$ 67 Mn in the commercial milestone payments.

“Growing occurrences of brain tumors are likely to take the glioblastoma treatment drugs market by storm in the near future”, says an analyst from Future Market Insights.

What’s the enclosure with glioblastoma treatment drugs market?

  • Future Market Insights offers an exclusive perspective and various real-time insights on the glioblastoma treatment drugs market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
  • The research study is based on drug class (antineoplastic, VEGF/VEGFR inhibitors, alkylating agents, and miscellaneous antineoplastic), and by distribution channel (hospitals, cancer research organizations, long term care centers, and diagnostic centers).
  • With increasing incidences of cancer coupled with rising geriatric population, the global glioblastoma treatment drugs market is likely to grow in an aplomb in the near future.

Key Players in the Glioblastoma Treatment Drugs Market are

  • F. Hoffmann-La Roche AG,
  • Merck & Co., Inc.,
  • Sandoz
  • Arbor Pharms LLC.
  • Emcure Pharmaceuticals Ltd.
  • Bristol-Myers Squibb Company
  • Sigma-Tau Pharmaceuticals, Inc.

Key Segments:

Based on the Drug Class:

  • Antineoplastic
  • VEGF/VEGFR Inhibitors
  • Alkylating Agents
  • Miscellaneous Antineoplastic

Based on the Distribution Channel:

  • Hospitals
  • Cancer Research Organizations
  • Long Term Care Centers
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more